Cigna CorpCI
▲ PositiveCapitalrelevance
Bernstein raised price target to $381, citing medical cost management and Evernorth performance.

Cigna shares jumped 3.5% after Bernstein raised its price target to $381 from $371, maintaining an Outperform rating. The analyst firm cited the company's ability to manage medical costs and the strong performance of its Evernorth division. Bernstein projected a better-than-consensus medical loss ratio and forecasted a 9.5% adjusted earnings per share growth rate through 2030. The new price target suggests significant potential upside from the stock's previous close.
Cigna CorpBernstein raised price target to $381, citing medical cost management and Evernorth performance.
British American Tobacco PLC